HLA-alleles determine the risk to develop antibodies against interferon-beta therapy in multiple sclerosis

Buck, D.D.BuckCepok, S.S.CepokHoffmann, S.S.HoffmannGrummel, V.V.GrummelLehmann-Horn, K.K.Lehmann-HornHackermüller, J.J.HackermüllerStadler, P.F.P.F.StadlerHartung, H.-P.H.-P.HartungBerthele, A.A.BertheleDeisenhammer, F.F.DeisenhammerWassmuth, R.R.WassmuthHemmer, B.B.Hemmer2022-03-042022-03-042009https://publica.fraunhofer.de/handle/publica/219465en610616HLA-alleles determine the risk to develop antibodies against interferon-beta therapy in multiple sclerosisjournal article